Centre releases COVID-19 funds to 22 states, UTs as tally nears 20 lakh; Kuwait approves repatriation flights to India

Centre releases COVID-19 funds to 22 states, UTs as tally nears 20 lakh; Kuwait approves repatriation flights to India

Centre releases COVID-19 funds to 22 states, UTs as tally nears 20 lakh; Kuwait approves repatriation flights to India

Thursday was the eighth consecutive day when day by day COVID-19 instances elevated by greater than 50,000, and fourth consecutive day India reported extra instances than the US, the worst hit nation on this planet.

India noticed a single day enhance of 56,282 COVID-19 instances taking the nation’s virus tally a step nearer to 20 lakh. Thursday was the eighth consecutive day that day by day instances elevated by greater than 50,000 and fourth consecutive day India reported extra instances than the US, the worst hit nation on this planet.

In keeping with the Union Well being Ministry knowledge knowledge up to date at eight am, India has 19,64,536 with 40,699 having succumed to the virus. Of those deaths, 904 fatalities had been  reported in 24-hours previous the morning replace.

There are 5,95,501 lively instances of coronavirus an infection within the nation presently which contribute to 30.31 p.c of the overall instances.

In the meantime, the overall variety of recoveries amongst COVID-19 sufferers in India has jumped to 13,28,336, pushing the restoration charge to 67.62 p.c on Thursday, whereas the case fatality charge has additional dropped to 2.07 p.c, the federal government stated.

Centre releases second tranche of package deal for well being preparedness

The Centre has launched Rs 890.32 crore because the second instalment of the COVID-19 Emergency Response and Well being System Preparedness package deal to 22 states and Union Territories, the Well being Ministry stated on Thursday.

The quantity of monetary help to every state and Union Territories is predicated on their COVID-19 caseload.

Those that obtained monetary help within the second instalment embody Chhattisgarh, Jharkhand, Madhya Pradesh, Odisha, Rajasthan, Telangana, Andhra Pradesh, Goa, Gujarat, Karnataka, Kerala, Punjab, Tamil Nadu, West Bengal, Arunachal Pradesh, Assam, Meghalaya, Manipur, Mizoram and Sikkim, the ministry stated.

Prime Minister Narendra Modi had introduced a Rs 15,000 crore package deal as a part of the ‘Complete of Authorities’ strategy whereby the Centre is main the COVID-19 response and administration, and supporting the states and UTs by means of technical and monetary assets.

The second instalment of the help might be used to strengthen public well being infrastructure for testing, together with procurement and set up of RT-PCR machines, RNA extraction kits, TrueNat and CB-NAAT machines, bolster infrastructure for therapy and improvement of ICU beds, set up of oxygen mills and procurement of bedside oxygen concentrators amongst others.

It could even be used for engagement, coaching and capability constructing of obligatory human assets and incentives to healthcare workforce and volunteers, together with ASHA staff on COVID-19 duties, the well being ministry stated, including that wherever obligatory, volunteers registered on the COVID Warriors portal might also be engaged in coronavirus duties.

CPM’s Shyamal Chakraborty dies of COVID-19

Senior CPM chief Shyamal Chakraborty died of COVID-19 at a hospital in Kolkata on Thursday, occasion sources stated. He was 76.

Chakraborty, the three-time transport minister of West Bengal from 1982 to 1996, was admitted to the hospital after he examined optimistic for COVID-19 on 30 July. He was additionally a two-time Rajya Sabha member and a veteran commerce unionist.

“He died this afternoon. He was on air flow for the previous few days,” a celebration chief stated.

He’s survived by daughter Ushasi Chakraborty, an actor.

Chakraborty is the second notable politician from the state to die of COVID-19. Trinamool Congress MLA Tamonash Ghosh succumbed to the contagion in June.

On Wednesday, Bidhannagar Municipal Company councillor Subhash Bose additionally died of COVID-19.

State-wise instances and deaths

Of the 904 contemporary deaths reported in Thursday morning replace, 334 are from Maharashtra, 112 from Tamil Nadu, 100 from Karnataka, 77 from Andhra Pradesh, 61 from West Bengal, 40 from Uttar Pradesh, 29 from Punjab, 23 from Gujarat, 17 from Madhya Pradesh, 13 every
from Rajasthan and Telangana, 11 from Delhi and 9 every from Jammu and Kashmir and Odisha.

Eight fatalities every have been reported from Bihar and Jharkhand, seven every from Haryana, Kerala and Puducherry, six from Assam, 4 from Goa, three from Uttarakhand, two every from Andaman and Nicobar Islands and Chhattisgarh, whereas Nagaland and Tripura have registered one fatality every.

Centre releases COVID19 funds to 22 states UTs as tally nears 20 lakh Kuwait approves repatriation flights to India

Representational picture. AP

Of the overall 40,699 deaths in India, Maharashtra has reported the utmost at 16,476 adopted by 4,461 in Tamil Nadu, 4,044 in Delhi, 2,804 in Karnataka, 2,556 in Gujarat, 1,857 in Uttar Pradesh, 1,846 in West Bengal, 1,681 in Andhra Pradesh and 929 in Madhya Pradesh.

To this point, 745 folks have died of COVID-19 in Rajasthan, 589 in Telangana, 491 in Punjab, 455 in Haryana, 426 in Jammu and Kashmir, 355 in Bihar, 225 in Odisha, 136 in Jharkhand, 121 in Assam, 98 in Uttarakhand, 94 in Kerala.

Chhattisgarh has registered 71 deaths, Puducherry 65, Goa 64, Tripura 31, Chandigarh 20, Himachal Pradesh and Andaman and Nicobar Islands 14 every, Ladakh and Manipur seven every, Nagaland six, Meghalaya 5, Arunachal Pradesh three, Dadra and Nagar Haveli and Daman and Diu two and Sikkim one.

AIIMS research casts doubts over plasma remedy’s efficacy

Convalescent plasma remedy didn’t present profit in lowering mortality threat amongst COVID-19 sufferers, in accordance with an interim evaluation of a randomised managed trial finished at AIIMS to evaluate the efficacy of this mode of therapy.

The remedy entails taking antibodies from the blood of an individual who has recovered from COVID-19 and transfusing these into an lively coronavirus contaminated affected person to assist kickstart the immune system to battle again the an infection.

AIIMS director Dr Randeep Guleria informed PTI that no clear mortality advantage of convalescent plasma remedy was seen throughout a trial carried out amongst 30 COVID-19 sufferers.

In the course of the trial, one group of sufferers was given convalescent plasma remedy together with the usual supportive therapy whereas the opposite group solely obtained customary therapy. The variety of fatalities recorded in each the teams was equal and there was not a lot medical enchancment within the situation of sufferers, he stated.

“Nonetheless, that is simply an interim evaluation and we have to do a extra detailed analysis to see if any sub-group could profit from plasma remedy,” Dr Guleria stated.

He additionally underlined that the plasma must be examined for its security and will have adequate antibody to be helpful to COVID-19 sufferers.

ICMR to arrange registry of hospitalised COVID-19 sufferers

The Indian Council of Medical Analysis (ICMR) has sought participation of establishments and hospitals recognized as devoted coronavirus hospitals or well being centres as a part of its venture to determine “Nationwide Medical Registry of COVID-19” to assist enhance therapy outcomes and analyse tendencies within the development of the pandemic.

The purpose is to develop a registry to gather knowledge concerning medical and laboratory options, remedies, and outcomes of hospitalised COVID-19 sufferers in India.

The target can be to review the frequency, medical and laboratory options, remedies, and outcomes of COVID-19 associated multisystem inflammatory dysfunction in kids and adolescents by analysing the nationwide COVID-19 registry, the ICMR stated.

Knowledge can be collected from 100 hospitals throughout the nation as a part of the venture.

“The NCRC will purpose at gathering good high quality, actual time medical knowledge to tell evidence-based medical apply, analysis, formulating pointers and coverage making,” the apex well being analysis physique.

The period of the research might be one yr.

Kuwait approves repatriation flights to India

Kuwait has authorized India’s request to run repatriation flights for residents wishing to return dwelling, even because the Gulf nation has imposed an indefinite journey ban on 31 “high-risk” coronavirus international locations, together with India, in accordance with a media report on Thursday.

Kuwait’s Directorate-Normal of Civil Aviation (DGCA) will function the repatriation flights from 10 August to 24 October, the Gulf Information reported, citing Kuwaiti newspaper Al Qabas.

The burden of flights might be shared equally between Indian and Kuwaiti airways and every day about 1,000 Indians will depart Kuwait Metropolis, the report stated.

Kuwait has a inhabitants of 48 lakhs with foreigners accounting for 34 lakhs. There are about 10 lakh Indian expatriates in Kuwait.

“The preparations proposed by the Indian facet are restricted to departure solely and don’t embody their return to Kuwait,” an official was quoted as saying within the report.

With inputs from PTI

#Centre #releases #COVID19 #funds #states #UTs #tally #nears #lakh #Kuwait #approves #repatriation #flights #India